MKI67 and neoplasm: Compared with the control group, both the 1 and 3 μM cisplatin chemotherapy groups presented significantly reduced tumor volumes (Figure 1C–E), with less weight loss in the mice (Figure 1F) but an increased incidence of neck lymph node metastasis and increased expression of Ki‐67 (Figure 1G,H).